Correlation Between Eterna Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on Eterna Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for Eterna Therapeutics and X4 Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eterna and XFOR is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eterna Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days Eterna Therapeutics is expected to generate 1.46 times more return on investment than X4 Pharmaceuticals. However, Eterna Therapeutics is 1.46 times more volatile than X4 Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest 126.00 in Eterna Therapeutics on July 21, 2024 and sell it today you would lose (24.00) from holding Eterna Therapeutics or give up 19.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Eterna Therapeutics vs. X4 Pharmaceuticals
Performance |
Timeline |
Eterna Therapeutics |
X4 Pharmaceuticals |
Eterna Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eterna Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite Eterna Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.Eterna Therapeutics vs. KBC Groep NV | Eterna Therapeutics vs. Pfizer Inc | Eterna Therapeutics vs. JPMorgan Chase Co | Eterna Therapeutics vs. Davis Select Worldwide |
X4 Pharmaceuticals vs. KBC Groep NV | X4 Pharmaceuticals vs. Pfizer Inc | X4 Pharmaceuticals vs. JPMorgan Chase Co | X4 Pharmaceuticals vs. Davis Select Worldwide |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |